Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Koerber Pharma Software in 2026: PAS-X, MES, and GMP Compliance Guide

Explore how PAS-X MES supports electronic batch records, production control, and data integrity in regulated pharmaceutical manufacturing. Learn which validation, access, audit trail, and lifecycle controls inspectors expect under 21 CFR Part 11 and EU GMP Annex 11.
  • Blog, Validation and Qualification
Pharmaceutical MES software interface showing PAS-X MES controls for electronic batch records, audit trails, electronic signatures, and batch release.

CSV in 2026: Computer System Validation for GMP Compliance

Computer system validation in pharma helps companies protect electronic records, control GxP risks, and maintain compliance throughout the validation lifecycle. This guide explains risk-based testing, audit trail review, access control, change control, and inspection-ready evidence.
  • Blog, Validation and Qualification
Pharmaceutical quality specialist reviewing a GxP dashboard for computer system validation in pharma, including audit trail review, access control, testing, and change control.

Pharmaceutical Warehouse in 2026: GMP Storage Requirements and Inspection Readiness

Discover how compliant pharmaceutical storage supports product quality, regulatory compliance, and inspection readiness. This guide explains warehouse controls, temperature mapping, environmental monitoring, cold chain management, and practical strategies that help reduce inspection findings while maintaining product integrity throughout the supply
  • Blog, Validation and Qualification

Pharma Temperature Monitoring in 2026: GMP Compliance Risks, Temperature Excursions, and Regulatory Findings

This article explains how temperature monitoring systems support pharmaceutical quality systems through temperature mapping, continuous temperature monitoring, and data logger control. It highlights cold chain monitoring, temperature excursions, and GDP compliance to improve inspection readiness and product safety.
  • Blog, Validation and Qualification
Pharmaceutical cold chain monitoring system showing temperature mapping, data logger tracking, and environmental monitoring used to prevent temperature excursions and ensure storage temperature control under GDP guidelines.

Equipment Qualification In Pharma in 2026: GMP Compliance Risks, Validation Failures, and Inspection Findings

Learn how pharmaceutical equipment qualification supports GMP compliance, inspection readiness, and lifecycle control. Explore common qualification failures, IQ OQ PQ qualification practices, requalification triggers, and equipment lifecycle management strategies that help reduce regulatory risk and inspection findings.
  • Blog, Validation and Qualification
Pharmaceutical equipment qualification process showing installation qualification, operational qualification, performance qualification, and equipment lifecycle management in a GMP manufacturing facility

Area Qualification In Pharma In 2026: HVAC Qualification, Cleanroom Control, and GMP Compliance Systems

Area qualification helps pharmaceutical manufacturers maintain cleanroom performance, HVAC effectiveness, and environmental control throughout the facility lifecycle. This guide explains qualification requirements, inspection risks, contamination control strategies, and ongoing activities that support GMP compliance and inspection readiness.
  • Blog, Validation and Qualification
GMP facility qualification with cleanroom classification, HVAC validation, environmental monitoring systems, and controlled manufacturing environments.

pharma qualification in 2026: GMP Failures, Validation Gaps, and Inspection Findings

This article explains pharma qualification as a GMP-controlled lifecycle covering equipment, facilities, and utilities. It highlights inspection findings, validation gaps, and regulatory expectations from FDA and EU GMP authorities, focusing on real-world compliance risks and system failures.
  • Blog, Validation and Qualification
Pharma qualification lifecycle and GMP validation concepts including IQ OQ PQ equipment qualification and data integrity requirements in pharmaceutical manufacturing systems

pharma regulatory bodies in 2026: FDA, EMA, WHO Roles, and Global GMP Control Systems

This article explores how pharma regulatory bodies such as FDA, EMA, and WHO shape global GMP compliance. It highlights inspection trends, data integrity requirements, and harmonized regulatory frameworks that drive pharmaceutical quality systems and inspection readiness worldwide.
  • Blog, Validation and Qualification
Illustration of FDA, EMA, and WHO regulatory bodies overseeing global GMP inspection readiness, pharmaceutical quality systems, and data integrity requirements in international drug regulatory frameworks.

CSV Documentation in 2026: GMP Compliance, Data Integrity, and Inspection Readiness

This article explains how CSV Documentation supports GMP compliance in computerized systems, focusing on validation traceability, IQ OQ PQ documentation, and data integrity requirements aligned with FDA 21 CFR Part 11 and EU Annex 11 expectations.
  • Blog, Validation and Qualification
Pharmaceutical validation documentation workflow for Computer System Validation (CSV) in GMP computerized systems, highlighting validation traceability matrix, IQ OQ PQ documentation, and compliance with GAMP 5 validation and data integrity standards.

Data in GMP in 2026: Data Integrity, Compliance Requirements, and Inspection Readiness Explained

This article explains how data in GMP is controlled across its lifecycle, focusing on pharmaceutical data integrity, audit trail review, and electronic records compliance. It highlights regulatory expectations under ALCOA+ principles, FDA guidance, and Annex 11 requirements for inspection readiness.
  • Blog, Validation and Qualification
Pharmaceutical laboratory scene showing digital systems and documentation processes related to GMP data integrity, audit trail review, and electronic records compliance under Annex 11 and 21 CFR Part 11 requirements.